Extracellular matrix and its therapeutic potential for cancer treatment
2021 · Signal Transduction and Targeted Therapy · 850 citations
https://doi.org/10.1038/s41392-021-00544-0
L
Lin Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
358
Papers
12.5K
Citations
56
h-index
220
i10-index
Lin Zhou is an academic researcher from Nanchang University. The author has contributed to research in topics: Organ Transplantation Techniques and Outcomes & Liver Disease and Transplantation & Liver Disease Diagnosis and Treatment. The author has an h-index of 56, co-authored 305 publications.
ORCID: 0000-0001-5689-3512Papers by this author
worksALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
2020 · Molecular Cancer · 296 citations
https://doi.org/10.1186/s12943-020-01239-w
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
2020 · Genome Medicine · 190 citations
https://doi.org/10.1186/s13073-020-00796-5
MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2
2014 · Journal of Translational Medicine · 117 citations
https://doi.org/10.1186/s12967-014-0259-1
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
2017 · Molecular Oncology · 105 citations
https://doi.org/10.1002/1878-0261.12067
HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
2018 · Journal of Experimental & Clinical Cancer Research · 73 citations
https://doi.org/10.1186/s13046-018-0866-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat